Geode Capital Management, LLC Biocept Inc Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.24 - $0.62 $812 - $2,099
-3,386 Reduced 2.46%
134,112 $45,000
Q4 2022

Feb 13, 2023
SELL
$0.47 - $0.89 $175 - $332
-374 Reduced 0.27%
137,498 $72,000
Q2 2022

Aug 12, 2022
BUY
$0.88 - $2.27 $6,287 - $16,219
7,145 Added 5.47%
137,872 $129,000
Q3 2021

Nov 12, 2021
SELL
$3.39 - $4.34 $13,980 - $17,898
-4,124 Reduced 3.06%
130,727 $524,000
Q2 2021

Aug 13, 2021
BUY
$4.03 - $5.07 $12,585 - $15,833
3,123 Added 2.37%
134,851 $565,000
Q1 2021

May 12, 2021
BUY
$4.74 - $7.94 $214,195 - $358,800
45,189 Added 52.22%
131,728 $670,000
Q3 2020

Nov 13, 2020
BUY
$3.61 - $11.4 $312,405 - $986,544
86,539 New
86,539 $381,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email